Ferroptosis: friend or foe in cancer immunotherapy?

Authors:
Demuynck R; Efimova I; Catanzaro E; Krysko DV.

Journal:
Oncoimmunology

Publication Year: 2023

DOI:
10.1080/2162402X.2023.2182992

PMCID:
PMC9980624

PMID:
36875549

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Oncoimmunology

Abbreviation: Oncoimmunology

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A bispecific anti-PD-1 and PD-L1 antibody induces PD-1 cleavage and provides enhanced anti-tumor ac…
Albu DI; Wolf BJ; Qin Y and 12 more (2024) - Transparency Score: 2/6
An oncogene regulating chromatin favors response to immunotherapy: Oncogene CHAF1A and immunotherap…
Ying L; Hu Z; Lu Y and 11 more (2024) - Transparency Score: 2/6
Arginase-1 specific CD8+ T cells react toward malignant and regulatory myeloid cells.
Glöckner HJ; Martinenaite E; Landkildehus Lisle T and 5 more (2024) - Transparency Score: 3/6
Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8<sup>+</sup>T cell func…
Wei W; Tian L; Zheng X and 6 more (2024) - Transparency Score: 3/6
Extracellular vesicles released by cancer-associated fibroblast-induced myeloid-derived suppressor …
Ramil CP; Xiang H; Zhang P and 10 more (2024) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure statement Authors declare no conflict of interests."

Evidence found in paper:

"The Cell Death Investigation and Therapy (CDIT) Laboratory led by DVK is supported by FWO-Flanders (G016221N; G043219N), Ghent University BOF (Special Research Fund; BOF/IOP01/O3618, BOF/IOP/2022/033, and BOF23/GOA/029). This project (40007488) has received funding from the FWO and F.R.S.-FNRS under the Excellence of Science (EOS) program. Robin Demuynck (11E3123N) and Iuliia Efimova (11F7723N) are Ph.D. students in the CDIT Laboratory, and they both hold Ph.D. fellowships from FWO-Flanders."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025